2020
DOI: 10.1002/hec.4035
|View full text |Cite
|
Sign up to set email alerts
|

‘More than one red herring'? Heterogeneous effects of ageing on health care utilisation

Abstract: We study the effect of ageing, defined as an extra year of life, on health care utilisation. We disentangle the direct effect of ageing, from other alternative explanations such as the presence of comorbidities and endogenous time to death (TTD) that are argued to absorb the effect of ageing (so‐called ‘red herring' hypothesis). We exploit individual level end of life data from several European countries that record the use of medicine, outpatient and inpatient care and long‐term care. Consistently with the ‘r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 63 publications
(88 reference statements)
0
9
0
Order By: Relevance
“…However, there may be other reasons or scenarios when withholding and "rationing" intensive care treatment may be deemed appropriate, especially for old people (29). Health economic considerations, which weigh the considerable costs of an intensive care stay with an associated high mortality on the one hand and the high morbidity among the survivors on the other, are understandable and necessary (30,31). However, it is well established, especially in the health economics' literature, that it is not the chronological age, but the remaining life expectancy, that predicts cost and morbidity and that these two are not necessarily the same thing (32).…”
Section: Discussionmentioning
confidence: 99%
“…However, there may be other reasons or scenarios when withholding and "rationing" intensive care treatment may be deemed appropriate, especially for old people (29). Health economic considerations, which weigh the considerable costs of an intensive care stay with an associated high mortality on the one hand and the high morbidity among the survivors on the other, are understandable and necessary (30,31). However, it is well established, especially in the health economics' literature, that it is not the chronological age, but the remaining life expectancy, that predicts cost and morbidity and that these two are not necessarily the same thing (32).…”
Section: Discussionmentioning
confidence: 99%
“…Breyer et al (2015) [ 27 ] Pseudo-panel 1997–2009, 2340 age and sex groups Germany Yes (Nadolski (2002) [ 53 ]; Thielscher et al (2012) [ 54 ]; Cylus and Papanicolas (2015) [ 52 ]) No 4. Costa-Font and Vilaplana-Prieto (2020) [ 31 ] Pseudo-panel, waves 1, 2 and 4–7 of SHARE, 288,600 observations 17 countries Yes (the majority of individuals sampled are subject to rationing) No 1 5. De Nardi et al (2016) [ 42 ] Panel 1996–2010, 67,000 Medicare enrollees United States No (Nelson (2011) [ 55 ]) Yes 6.…”
Section: Figure A1mentioning
confidence: 99%
“…It is also well known that, rather than the natural age, it is the final stage of a person's life that better determines their use of healthcare resources. [25][26][27] One of the explanatory factors is the cause of death, with oncological diseases being the ones associated with higher expenses. 28 Access to end-of-life healthcare services is highly variable, with the worst impact on the most deprived SEC groups, 29 also being true in the case of access to palliative care.…”
Section: What This Study Addsmentioning
confidence: 99%